RE: RNS11 Jul 2022 15:10
Meki - the shares DB ventures subscribed for like all IPO placement offers was at 5p.
‘The Company has been admitted to the standard segment of the Official List following a significantly oversubscribed initial public offering that raised £13 million before expenses for the Company.
More than 6,000 valid applications for shares were received in respect of the IPO.
Cellular Goods is the first provider of premium consumer products based on biosynthetic cannabinoids to join the London stock market.
‘A total of 260,000,000 ordinary shares (representing 51.5% of the Company's issued share capital on Admission) have been issued at 5 pence each to institutional and retail investors, valuing Cellular Goods at a market capitalisation in excess of £25 million.’
Their original investment heading now under 50k when this drops below a penny from 250k
IMHO DYOR GLA